| 翻訳と辞書 |
| Oncofertility Consortium ： ウィキペディア英語版 |
Oncofertility Consortium
The Oncofertility Consortium is a multi-institutional group that assessed the impact of cancer and its treatment on reproductive health. The term oncofertility refers to an interdisciplinary field that bridges oncology, reproduction, and women’s health research for the purpose of exploring and expanding options for the reproductive future of cancer patients. Clinical care for such patients may include fertility preservation prior to medical interventions as well as family planning, complex contraception, and hormonal management across the cancer survivor's lifespan. The term was coined in 2006 by Dr. Teresa Woodruff, at the Feinberg School of Medicine (Northwestern University). Woodruff is the Thomas J. Watkins Professor of Obstetrics and Gynecology at Feinberg.
== History==
Cancer research has blossomed significantly since the signing of the National Cancer Act in 1971. With greater support for clinical and basic science research in cancer detection, diagnosis, and treatment, which was conducted by the newly developed National Cancer Institute (NCI), cancer survival rates rose rapidly. Currently, 75% of pediatric cancer patients survive. Thus, support for the NCI and its affiliates has greatly improved the quality of life for a large number of cancer patients.
However, despite new hope for survival, many men, women, and children diagnosed with cancer experience impaired reproductive function as a result of the rigorous therapies they undergo as part of their cancer treatment and, thus, face unique challenges in planning their lives after cancer.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Oncofertility Consortium」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|